{"id":"197db0704ca8","type":"article","url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neo-atherosclerose-na-stemi/","title":"LDL-cholesterol en neo-atherosclerose na STEMI","title_en":"Low-Density Lipoprotein Cholesterol Levels and Neoatherosclerosis After STEMI","category":"cholesterol","category_label":"Cholesterol","professions":["apotheker","cardioloog"],"tags":["cetp-remmers","ezetimibe","hdl-cholesterol","ldl-cholesterol","lipidenverlaging","statines"],"journal":"JAMA Cardiology","doi":"https://jamanetwork.com/journals/jamacardiology/fullarticle/2843037","source_url":"https://doi.org/https://jamanetwork.com/journals/jamacardiology/fullarticle/2843037","authors":[],"significance":7,"published":"2026-02-01","source_date":"2026-02-01","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/ldl-cholesterol-mechanisme/","https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/"],"congress":"","summary_en":"This secondary analysis of the CONNECT trial evaluated whether achieving guideline-endorsed LDL cholesterol levels after drug-eluting stent implantation for STEMI reduces neoatherosclerosis development within the stented segment.","created":"2026-07-03T10:25:27Z","updated":"2026-07-03T13:24:52Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Secundaire analyse van de CONNECT-trial over de vraag of het bereiken van richtlijn-conforme LDL-cholesterolwaarden na drug-eluting stentplaatsing bij STEMI-patiënten neo-atherosclerose voorkomt.","abstract_original":"This secondary analysis of the CONNECT randomized clinical trial evaluates whether achieving a guideline-endorsed low-density lipoprotein cholesterol level after drug-eluting stent implantation in patients with ST-segment elevation myocardial infarction (STEMI) is associated with reduced risk of long-term neoatherosclerosis formation."}